NCT00255684 · OUTCOME
Number of Participants Who Developed Acute Graft Versus Host Disease
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- 3 months
Groups in this outcome
Conditioning Therapy Followed by TBI
Fludarabine, Cyclophosphamide; Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil graft-versus-tumor prophylaxis therapy cyclophosphamide cyclosporine fludarabine phosphate mycophenolate mofetil umbilical cord blood transplantation radiation therapy
| Group | Source count |
|---|---|
| Conditioning Therapy Followed by TBI | 16 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Conditioning Therapy Followed by TBI | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 0
- denoms
- counts
- group Id
- OG000
- value
- 16
- units
- Participants
- groups
- description
- Fludarabine, Cyclophosphamide; Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil graft-versus-tumor prophylaxis therapy cyclophosphamide cyclosporine fludarabine phosphate mycophenolate mofetil umbilical cord blood transplantation radiation therapy
- id
- OG000
- title
- Conditioning Therapy Followed by TBI
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 3 months
- title
- Number of Participants Who Developed Acute Graft Versus Host Disease
- type
- SECONDARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle